Bleomycin Powder, For Solution
Product Images NDC 71288-106

5 FDA label images from Meitheal Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Bleomycin (NDC 71288-106). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Ble05 0000 01)

Figure (Ble05 0000 01)
Chemical structure diagram of the active ingredient Bleomycin Sulfate, showing its molecular components and bonds.*
FDA Label Image

15 Unit Vial (Ble05 0000 02 V2)

15 Unit Vial (Ble05 0000 02 V2)
Bleomycin for Injection, USP 15 units per vial, powder for solution vial label. The label cautions that the product is a cytotoxic agent and must be diluted before use. It is intended for intravenous, intramuscular, subcutaneous, or intrapleural use. The label includes storage instructions, manufacturer information for Meitheal Pharmaceuticals Inc., and a barcode.*
FDA Label Image

15 Unit Carton (Ble05 0000 04 V2)

15 Unit Carton (Ble05 0000 04 V2)
Packaging label for Bleomycin for Injection, USP 15 units per vial powder for solution. The label indicates a single-dose vial with caution as a cytotoxic agent. It is labeled for intravenous, intramuscular, subcutaneous, or intrapleural use. Manufactured for Meitheal Pharmaceuticals Inc., Chicago, IL, and made in China. Storage instructions and sterile, preservative-free status are also included.*
FDA Label Image

30 Unit Vial (Ble05 0000 03 V2)

30 Unit Vial (Ble05 0000 03 V2)
Label for Bleomycin for Injection, USP, 30 units per vial, powder for solution. The label indicates the product is a single-dose vial requiring dilution for intravenous, intramuscular, subcutaneous, or intrapleural use. It is identified as a cytotoxic agent with storage instructions to keep refrigerated between 36°F and 46°F. Manufactured by Meitheal Pharmaceuticals Inc., Chicago, IL, and product of China.*
FDA Label Image

30 Unit Carton (Ble05 0000 05)

30 Unit Carton (Ble05 0000 05)
The image shows the flat layout of the packaging label for Bleomycin for Injection, USP, 30 units per vial powder for solution. The label indicates this is a single-dose vial requiring dilution for intravenous, intramuscular, subcutaneous, or intrapleural use. It includes cautions stating it is a cytotoxic agent and provides storage instructions. The labeler is Meitheal Pharmaceuticals Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.